Biomarker technology roundup: from discovery to clinical applications, a broad set of tools is required to translate from the lab to the clinic.

Biomarkers are being utilized throughout the drug discovery and development process to understand fundamental biological processes and relationships. Specific biomarkers for disease states, prognosis, and response to therapy have been applied to screening tissues and serum, and serve as new tools in the development of therapeutics, to segment the population for specific treatments. The use of specific biomarkers to screen subjects to determine clinical trial eligibility, and for early toxicology studies, holds the potential to decrease drug failure rates in the later phases of the clinical trial process.

Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.

Bullous pemphigoid (BP) is an acquired bullous disorder that predominantly affects the elderly. It is rare in children but when it occurs, there is considerable clinical and histologic overlap with other acquired or congenital blistering disorders. A definitive diagnosis of childhood BP requires direct immunofluorescence and, in some cases, characterization of the target antigen.

Neonatal outcome after trial of labor compared with elective repeat cesarean section.

Background: Trial of labor after cesarean section has been an important strategy for lowering the rate of cesarean delivery in the United States, but concerns regarding its safety remain. The purpose of this study was to evaluate the outcome of newborns delivered by elective repeat cesarean section compared to delivery following a trial of labor after cesarean.

Methods: All low-risk mothers with 1 or 2 previous cesareans and no prior vaginal deliveries, who delivered at our institution from December 1994 through July 1995, were identified.

Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.

Background: Long-term consequences of juvenile dermatomyositis (JDM) include onset of calcinosis and subsequent functional impairment. Historic incidence of calcinosis has been reported between approximately 23% and 70%. Recent reports note improved outcome with high-dose steroids, yet the incidence of calcinosis has remained above 30%.

Phenotype of blood lymphocytes in PTSD suggests chronic immune activation.

Patients with posttraumatic stress disorder (PTSD) have a past history of extremely stressful experience and often present with somatic complaints. Peripheral blood lymphocytes (PBL) of patients with PTSD associated with a history of childhood sexual abuse were examined for changes in immune phenotype. The ratio of CD45RO-positive to CD45RA-positive lymphocytes (CD45RO/CD45RA), an index of lymphocyte activation, was higher (P = 0.